Protective immunity to Salmonella enterica is partially serogroup specific
- PMID: 23830894
- DOI: 10.1016/j.vetimm.2013.06.007
Protective immunity to Salmonella enterica is partially serogroup specific
Abstract
Pre-harvest reduction of Salmonella carriage by swine would benefit both animal health and food quality. While vaccination is an attractive pre-harvest intervention to reduce Salmonella levels in swine, the large number of potential Salmonella enterica serovars found in swine makes it critical that vaccines provide broad serotype efficacy. In order to directly compare the relative efficacy of Salmonella vaccines against serogroup-matched and serogroup-unmatched Salmonella, we vaccinated pigs with two commercially available Salmonella vaccines (either serogroup B or serogroup C1) and challenged with serovar-matched, serogroup-matched or serogroup-unmatched challenge strains. We found that while serogroup-matched vaccines provided relatively better efficacy than unmatched vaccines, serotype-unmatched vaccines also provided significant reduction of Salmonella carriage and shed. In addition, by measuring serogroup specific cell mediated (IFN-γ ELISPOT) and humoral (anti-LPS ELISA) immunity, we found that this serogroup specific efficacy correlates primarily with humoral immunity, while cell mediated immunity was mostly non-serogroup specific. While the practical relevance to pork quality of this serogroup-specific efficacy remains to be demonstrated, the large predominance of serogroup B Salmonella in swine suggests that a serogroup B Salmonella vaccine for swine would be of value to pre-harvest food safety interventions in swine.
Keywords: Immunity; Salmonella enterica; Sus scrofra; Swine; Vaccine.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine.J Med Microbiol. 2017 May;66(5):651-661. doi: 10.1099/jmm.0.000482. Epub 2017 May 18. J Med Microbiol. 2017. PMID: 28516860 Free PMC article.
-
Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms.Vet J. 2014 Nov;202(2):303-8. doi: 10.1016/j.tvjl.2014.09.012. Epub 2014 Sep 16. Vet J. 2014. PMID: 25278382
-
Maternal vaccination as a Salmonella Typhimurium reduction strategy on pig farms.J Appl Microbiol. 2018 Jan;124(1):274-285. doi: 10.1111/jam.13609. Epub 2017 Nov 27. J Appl Microbiol. 2018. PMID: 29024207
-
Salmonella Vaccination in Pigs: A Review.Zoonoses Public Health. 2017 Feb;64(1):1-13. doi: 10.1111/zph.12256. Epub 2016 Feb 8. Zoonoses Public Health. 2017. PMID: 26853216 Review.
-
Efficacy of vaccines against bacterial diseases in swine: what can we expect?Vet Microbiol. 2004 Jun 3;100(3-4):255-68. doi: 10.1016/j.vetmic.2004.03.002. Vet Microbiol. 2004. PMID: 15145504 Review.
Cited by
-
Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs.Vet Res. 2022 Apr 18;53(1):31. doi: 10.1186/s13567-022-01047-8. Vet Res. 2022. PMID: 35436975 Free PMC article.
-
A Systematic Review on the Effectiveness of Pre-Harvest Meat Safety Interventions in Pig Herds to Control Salmonella and Other Foodborne Pathogens.Microorganisms. 2021 Aug 27;9(9):1825. doi: 10.3390/microorganisms9091825. Microorganisms. 2021. PMID: 34576721 Free PMC article. Review.
-
Prime-boost vaccination with attenuated Salmonella Typhimurium ΔznuABC and inactivated Salmonella Choleraesuis is protective against Salmonella Choleraesuis challenge infection in piglets.BMC Vet Res. 2017 Sep 11;13(1):284. doi: 10.1186/s12917-017-1202-5. BMC Vet Res. 2017. PMID: 28893256 Free PMC article. Clinical Trial.
-
Salmonella Infection in Pigs: Disease, Prevalence, and a Link between Swine and Human Health.Pathogens. 2023 Oct 21;12(10):1267. doi: 10.3390/pathogens12101267. Pathogens. 2023. PMID: 37887782 Free PMC article. Review.
-
Inflammatory and Humoral Immune Responses to Commercial Autogenous Salmonella Bacterin Vaccines in Light-Brown Leghorn Pullets: Primary and Secondary Vaccine Responses.Vaccines (Basel). 2025 Mar 13;13(3):311. doi: 10.3390/vaccines13030311. Vaccines (Basel). 2025. PMID: 40266196 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources